Cite
MLA Citation
Brigitte Pegourie et al.. “Apixaban for the prevention of thromboembolism in immunomodulatory‐treated myeloma patients: Myelaxat, a phase 2 pilot study.” American journal of hematology, vol. 94, no. 6, n.d., pp. 635–640. http://access.bl.uk/ark:/81055/vdc_100082274167.0x000038